References
- Ansel H. C. Peroral solids, capsules, tablets and controlled release dosage forms. Introduction to Pharmaceutical Dosage Forms, h edn. Lea & Febiger, Philadelphia 1985; 167–176
- Bechgaard H. Critical factors influencing gastrointestinal absorption—what is the role of pellets. Acta Pharmaceutica Technology 1982; 28: 149–157
- Bidah D., Vergnaud J. M. Dosage forms with a polymer matrix and a swelling polymer. International Journal of Pharmaceutics 1991; 77: 81–87
- Bodmeier R., Paeratakul O. Propanolol HCL release from acrylic films prepared from aqueous latexes. International Journal of Pharmaceutics 1990; 9: 197–204
- Bodmeier R., Paeratakul O. Process and formulation variables affecting the drug release from chlorpheniramine maleate loaded beads coated with commercial and self prepared aqueous ethyl cellulose pseudolatexes. International Journal of Pharmaceutics 1991; 70: 59–68
- Cartwri Cht A. A. Controlled release—a regulatory dilemma. Manufacturing Chemist 1987; 58: 33–42
- Ciimg R. K., Rudnic E. M. The effect of various polymeric coating systems on the dissolution and tabletting properties of potassium chloride capsules. International Journal of Pharmaceutics 1991; 70: 261–270
- Ciietty D. J. Pharmaceutical availability studies on newly formulated sustained release pellets of diethylpropion hydrochloride. University of Durban-Westville. 1990, MPharm thesis
- Chetty D. J., Dangor C. M. The development of an oral controlled release pellets formulation of diethylpropion hydrochloride. Drug Development and Industrial Pharmacy 1993; 20: 993–1005
- Eudrac;ltrr Data Sheets. Rohm Pharma, DarmstadtGermany 1989
- Ghebre- Sellasie I., Gordon R. H., Middleton D. L., Nesbitt R. U., Fawzi M. B. A unique application and characterization of EudragitRR N film coatings in sustained release formulations. International Journal of Pharmaceutics 1986; 31: 43–54
- Gilligan C. A., PO L. W. A. Factors affecting drug release from a pellet system coated with an aqueous colloidal dispersion. International Journal of Pharmaceutics 1991; 73: 51–68
- Govender T. Formulation of contolled release pellets for oral use: an approach to optimising the pharmaceutical availability of salbutamol sulphate. University of Durban-Westville. 1992, MPharm thesis
- Govender T., Dangor C. M., Chetty D. J. Drug release and surface morphology studies on salbutamol controlled release pellets. Drug Development and Industrial Pharmacy 1995; 12: 1303–1322
- Hussey E. K., Donn K. H., Powell R., Lahey A. P., Rakes G. E. Albuterol extended release products: effect of food on the Pharmacokinetics of single oral doses of VolmaxR and ProventilR in healthy male volunteers. Journal of Clinical Pharmacology 1991; 31: 561–564
- Khan M. Z. I. Recent trends and progress in sustained or controlled oral delivery of some water soluble drugs: morphine salts, diltiazem and captopril. Drug Development and Industrial Pharmacy 1995; 21: 1037–1070
- Jamriiixar S. S., Breen P. J., Rojanasakul Y. Influence of formulation and other factors on the release of chlorpheniramine maleate from polymer coated beads. Drug Development and Industrial Pharmacy 1987; 13: 2789–2810
- Lordi N. G. Sustained release dosage forms. The Theory and Practice of Industrial Pharmacy, d edn., H. A. Lachman, J. L. Kanig. Lee & Febiger, Philadelphia 1986; 430–456
- MaiaX Iataris S., Avgerinos A. Bioavailability of controlled release indo-methacin microspheres and pellets. International Journal of Pharmaceutics 1990; 63: 77–80
- Siiarge I. L., Yu A. B. C. Controlled release drug products. Applied Biopharmacokinetics, d edn. Appleton Century-Crafts, Norwalk 1985; 347–371
- United State Pharmacopoeia (USP) XXII. Mack, Easton 1990